Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide in the Chilean National Health System. a Single Center Study

Bárbara Puga, Rafael Benavente, Francisca Bass, M. Javiera Molina, Alejandro Andrade, Alejandro Majlis, Maria Elena Cabrera, Soledad Undurraga

Blood (2023) 142 (Supplement 1): 6979.

https://doi.org/10.1182/blood-2023-174966

Published: 2023

Journal Articles

Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170

Pier Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, A. Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Herve Ghesquieres, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand

Blood (2023) 142 (2): 141–145.

https://doi.org/10.1182/blood.2022019340

Published: 2023

Journal Articles

Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Pier Luigi Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Waleswski, Alejandro Majlis, Laura Fogliatto, Alejandro Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Gilles Salles, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand

Blood (2021) 138 (Supplement 1): 306.

https://doi.org/10.1182/blood-2021-148082

Published: 2021

Journal Articles

Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study

Pier Luigi Zinzani, MD, Vladimir Melnichenko, Krimo Bouabdallah, MD, Jan Walewski, MD PhD, Alejandro Majlis, MD, Laura Fogliatto, MDPhD, Dolores Caballero, MD PhD, Beth A. Christian, MD, Zafer Gulbas, MD, Muhit Özcan, MD, Gilles Salles, MD PhD, Margaret A. Shipp, MD, Seth Thompson, Robert J Orlowski, MD, Patricia Marinello, Philippe Armand, MD PhD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-137080

Published: 2020

Journal Articles

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Camila Peña, MD, Gonzalo P Mendez, MD, Natalia Paola Schutz, MD, Eloisa Riva, MD, Ricardo Valjalo, MD, Hernán López-Vidal, MD, Alejandro Majlis, MD, Vivianne Lois, MD, Daniela Zamora, MD, Jose T Gonzalez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 5856.

https://doi.org/10.1182/blood-2018-99-113198

Published: 2018

Journal Articles

Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMBCL): Updated Analysis of the Keynote-170 Phase 2 Trial

Pier Luigi Zinzani, MD, Catherine Thieblemont, MD PhD, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, MD PhD, Alejandro Majlis, MD, Laura Fogliatto, MD, Dolores Caballero, MD PhD, Beth Christian, MD, Zafer Gulbas, MD, Muhit Özcan, MD, Gilles Andre Salles, MD PhD, Margaret A. Shipp, MD, Arkendu Chatterjee, Robert J Orlowski, Arun Balakumaran, MD PhD, Philippe Armand, MD PhD

Blood (2017) 130 (Supplement 1): 2833.

https://doi.org/10.1182/blood.V130.Suppl_1.2833.2833

Published: 2017

Journal Articles

Predictors of Stem Cell Yield Via Apheresis in Patients Undergoing Stem Cell Mobilization,

Rima M Saliba, Ph.D., Alexandre Chiattone, MD, Alejandro Majlis, MD, Viviane C. Chiattone, RN, Gabriela Rondon, MD, Araci M. Sakashita, MD, Nelson Hamerschlak, MD, Jose Mauro Kutner, MD, PhD, Elizabeth J Shpall, MD, Paolo Anderlini, MD, Issa Khouri, MD, Muzaffar H Qazilbash, MD, Uday Popat, M.D., Richard Champlin, MD, Chitra M Hosing, MD, Marcos De Lima, MD

Blood (2011) 118 (21): 4058.

https://doi.org/10.1182/blood.V118.21.4058.4058

Published: 2011

NARROW

Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide in the Chilean National Health System. a Single Center Study

Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170

Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMBCL): Updated Analysis of the Keynote-170 Phase 2 Trial

Predictors of Stem Cell Yield Via Apheresis in Patients Undergoing Stem Cell Mobilization,

Email alerts

ASH Publications

American Society of Hematology

Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide in the Chilean National Health System. a Single Center Study

Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170

Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMBCL): Updated Analysis of the Keynote-170 Phase 2 Trial

Predictors of Stem Cell Yield Via Apheresis in Patients Undergoing Stem Cell Mobilization,

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only